Pneumocystis Jiroveci Pneumonia
Symptoms, Doctors, Treatments, Advances & More

Learn About Pneumocystis Jiroveci Pneumonia

What is the definition of Pneumocystis Jiroveci Pneumonia?

Pneumocystis jirovecii pneumonia is a fungal infection of the lungs. The disease used to be called Pneumocystis carinii or PCP pneumonia.

What are the alternative names for Pneumocystis Jiroveci Pneumonia?

Pneumocystis pneumonia; Pneumocystis; PCP; Pneumocystis carinii; PJP pneumonia

What are the causes of Pneumocystis Jiroveci Pneumonia?

This type of pneumonia is caused by the fungus Pneumocystis jirovecii. This fungus is common in the environment and rarely causes illness in healthy people.

However, it can cause a lung infection in people with a weakened immune system due to:

  • Cancer
  • Long-term use of corticosteroids or other medicines that weaken the immune system
  • HIV/AIDS
  • Organ or bone marrow transplantation

Pneumocystis jirovecii was a rare infection before the AIDS epidemic. Before the use of preventive antibiotics for the condition, most people in the United States with advanced AIDS developed this infection.

What are the symptoms of Pneumocystis Jiroveci Pneumonia?

Pneumocystis pneumonia in people with AIDS usually develops slowly over days to weeks or even months, and is less severe. People with pneumocystis pneumonia who do not have AIDS usually get sick faster and are more severely ill.

Symptoms include:

  • Cough, often mild and dry
  • Fever
  • Rapid breathing
  • Shortness of breath, especially with activity (exertion)
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Pneumocystis Jiroveci Pneumonia?

Anti-infection medicines can be given by mouth (orally) or through a vein (intravenously), depending on how severe the illness is.

People with low oxygen levels and moderate to severe disease are often prescribed corticosteroids as well.

Who are the top Pneumocystis Jiroveci Pneumonia Local Doctors?
Elite in Pneumocystis Jiroveci Pneumonia
Pulmonary Medicine
Elite in Pneumocystis Jiroveci Pneumonia
Pulmonary Medicine
Referral may be required

Mayo Clinic-Rochester

5716 Cleveland St Ste 200, 
Virginia Beach, VA 
Languages Spoken:
English
Accepting New Patients

Andrew Limper is a Pulmonary Medicine provider practicing medicine in Virginia Beach, Virginia. Dr. Limper is rated as an Elite provider by MediFind in the treatment of Pneumocystis Jiroveci Pneumonia. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Pneumocystis Jiroveci Pneumonia, Pneumonia, Pulmonary Fibrosis, and Idiopathic Pulmonary Fibrosis. Dr. Limper is currently accepting new patients.

Elite in Pneumocystis Jiroveci Pneumonia
Infectious Disease
Elite in Pneumocystis Jiroveci Pneumonia
Infectious Disease
Referral may be required

Limited To Official Federal Duties Only

9000 Rockville Pike, 
Bethesda, MD 
Languages Spoken:
English

Joseph Kovacs is an Infectious Disease provider practicing medicine in Bethesda, Maryland. Dr. Kovacs is rated as an Elite provider by MediFind in the treatment of Pneumocystis Jiroveci Pneumonia. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Pneumocystis Jiroveci Pneumonia, Pneumonia, HIV/AIDS, and Primary Amebic Meningoencephalitis.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Pneumocystis Jiroveci Pneumonia
Elite in Pneumocystis Jiroveci Pneumonia
Referral may be required
ON, CA 

Seyed Moghaddam-Hosseini practices practicing medicine in Canada. Mr. Moghaddam-Hosseini is rated as an Elite expert by MediFind in the treatment of Pneumocystis Jiroveci Pneumonia. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Pneumocystis Jiroveci Pneumonia, Pneumonia, Cytomegalic Inclusion Disease, Kidney Transplant, and Lung Transplant.

What is the outlook (prognosis) for Pneumocystis Jiroveci Pneumonia?

Pneumocystis pneumonia can be life threatening. It can cause respiratory failure that can lead to death. People with this condition need early and effective treatment. For moderate to severe pneumocystis pneumonia in people with HIV/AIDS, the short term use of corticosteroids has decreased the incidence of death.

What are the possible complications of Pneumocystis Jiroveci Pneumonia?

Complications that may result include:

  • Pleural effusion (extremely rare)
  • Pneumothorax (collapsed lung)
  • Respiratory failure (may require breathing support)
When should I contact a medical professional for Pneumocystis Jiroveci Pneumonia?

If you have a weakened immune system due to AIDS, cancer, transplantation, or corticosteroid use, contact your provider if you develop a cough, fever, or shortness of breath.

How do I prevent Pneumocystis Jiroveci Pneumonia?

Preventive therapy is recommended for:

  • People with HIV/AIDS who have CD4 counts below 200 cells/microliter or 200 cells/cubic millimeter
  • Bone marrow transplant recipients
  • Organ transplant recipients
  • People who take long-term, high-dose corticosteroids
  • People who have had previous episodes of this infection
  • People who take long-term immunomodulatory medicines
What are the latest Pneumocystis Jiroveci Pneumonia Clinical Trials?
Phase I/II Safety lead-in Randomized Blind Placebo-controlled Clinical Trial: Efficacy and Safety of Caspofungin Aerosols for the Curative Treatment of Pneumocystis Pneumonia in Adjunction of Conventional Systemic Antifungal Therapy

Summary: To assess the efficacy of administrating daily caspofungin aerosols versus placebo for seven days, in adjunction of conventional systemic antifungal therapy during curative treatment of Pneumocystis pneumonia, on the clinical outcome at the end of the nebulized therapy, in order to support a GO / NO GO decision towards a phase III trial of nebulized caspofungin in those patients.

Match to trials
Find the right clinical trials for you in under a minute
Get started
Atovaquone Combined With Radiation in Children With Malignant Brain Tumors

Summary: The goal of this interventional study is to Assess the safety and tolerability of atovaquone in combination with standard radiation therapy (RT) for the treatment of pediatric patients with newly diagnosed pediatric high-grade glioma/diffuse midline glioma/diffuse intrinsic pontine glioma (pHGG/DMG/DIPG). The secondary aim is to assess the safety and tolerability of longer-term atovaquone treatmen...

Who are the sources who wrote this article ?

Published Date: December 13, 2025
Published By: Jatin M. Vyas, MD, PhD, Roy and Diana Vagelos Professor in Medicine, Columbia University Vagelos College of Physicians and Surgeons, Division of Infectious Diseases, Department of Medicine, New York, NY. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

What are the references for this article ?

Kovacs JA. Pneumocystis pneumonia. In: Goldman L, Cooney KA, eds. Goldman-Cecil Medicine. 27th ed. Philadelphia, PA: Elsevier; 2024:chap 313.

Smulian AG, Miller-Handley H, Miller RF. Pneumocystis species. In: Blaser MJ, Cohen JI, Holland SM, et al, eds. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 10th ed. Philadelphia, PA: Elsevier; 2026:chap 275.